NCT04631601: An ongoing trial by Amgen
This trial is completed, but has been granted a delay in reporting its results.
It must report results 10 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04631601 |
|---|---|
| Title | A Master Protocol Evaluating the Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 15, 2021 |
| Completion date | Oct. 23, 2023 |
| Required reporting date | Oct. 23, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |